Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Relypsa Inc (NASDAQ:RLYP)

During the Trading Day
24.12 +1.61 / +7.15%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
24.25 +0.13 / +0.54%
Volume: 13.3K
Health Technology
Pharmaceuticals: Other

Company Description

Relypsa, Inc. operates as a bio-pharmaceutical company focused on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases. Its products include patiromer, a non-absorbed for the treatment of hyperkalemia and RLY6002, polymer drug discovery technology. The company was founded on October 29, 2007 and is headquartered in Redwood City, CA.

Contact Information

Relypsa, Inc.
100 Cardinal Way
Redwood City California 94063
P:(650) 421-9500
Investor Relations:



Other institutional56.10%
Mutual fund holders39.23%
Individual stakeholders32.39%

Top Executives

John A. OrwinPresident, Chief Executive Officer & Director
Kristine McClintock BallChief Financial Officer & Senior Vice President
Wilhelm StahlChief Technology Officer & Senior Vice President
Lance BermanChief Medical Officer & Senior Vice President
Stephen D. HarrisonChief Scientific Officer & Senior Vice President